Corinne Savill
Corporate Officer/Principal presso CULLINAN THERAPEUTICS, INC.
Patrimonio netto: 5 M $ in data 31/05/2024
Profilo
Corinne Savill is currently the Chief Business Officer at Cullinan Therapeutics, Inc. She previously held positions as the Chief Executive Officer at Imutran Ltd.
from 1997 to 2001, Director at Cantargia AB in 2018, and Global Head of Business Development & Licensing at Novartis Pharma AG from 2013 to 2017.
She also served as the Head of Business Development & Licensing at Novartis Pharmaceuticals Corp.
Dr. Savill has an undergraduate degree from The University of Manchester and a doctorate degree from Middlesex School.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 22/02/2024 | 203 490 ( 0.35% ) | 5 M $ | 31/05/2024 |
Posizioni attive di Corinne Savill
| Società | Posizione | Inizio |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2017 |
Precedenti posizioni note di Corinne Savill
| Società | Posizione | Fine |
|---|---|---|
| CANTARGIA AB | Direttore/Membro del Consiglio | 21/05/2018 |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/02/2017 |
| Imutran Ltd. | Amministratore Delegato | 01/01/2001 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Formazione di Corinne Savill
| The University of Manchester | Undergraduate Degree |
| Middlesex School | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CANTARGIA AB | Health Technology |
| CULLINAN THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Cullinan Oncology LLC
Cullinan Oncology LLC Financial ConglomeratesFinance Cullinan Oncology LLC is a biopharmaceutical company, which engages in the development of a pipeline of targeted oncology and immuno-oncology therapies for cancer diseases. The company was founded by Patrick Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA. | Finance |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Health Technology |
| Imutran Ltd. | |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Corinne Savill
